HIV Clinical Trials Industry Overview
The global HIV clinical trials market size was valued at USD 1.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.3% from 2022 to 2030. The market growth is due to a rise in R&D investment in HIV clinical trials by pharmaceutical and biotechnology companies, increasing drug approvals for HIV, and increasing incidence of HIV in the population. This growth was halted due to the COVID-19 pandemic as the sudden surge in the pandemic resulted in the slow enrollment of trials and a sudden shift in the COVID-19 drug trials.
The government announced stay-at-home orders due to the COVID-19 pandemic that caused disruption and restricted HIV testing and diagnosis, which led to a steep slowdown in referral and treatment for HIV and AIDS. However, from the start of 2021, the increasing prevalence of HIV among people and their inability to be treated due to staying at home will create a large patient pool and lead to the development of new treatment methods to prevent HIV infection. This will lead to the growth of the market.
Gather more insights about the market drivers, restraints, and growth of the Global HIV Clinical Trials Market
A large number of non-profit organizations and pharmaceutical and biotechnology companies are investing in HIV clinical research industry for its treatment therapies. For instance, in April 2021, non-profit organizations: IAVI and Scripps Research announced that they had completed a phase I clinical trial for a novel vaccine against HIV. In addition, Excision has announced that the FDA has approved its Investigational New Drug (IND) as a treatment to cure chronic HIV, which is called EBT-101.
Numerous drug improvements have occurred in recent years as a result of the increased expenditure on HIV drug research and development. For instance, in December 2021, ViiV Healthcare announced the use of a Food and Drug Administration (FDA) accepted treatment to prevent HIV-1 infection that is acquired sexually, namely Apretude. It is a long-acting injectable pre-exposure prophylaxis (PrEP) for the treatment of the disease.
Browse through Grand View Research's Medical Devices Industry Related Reports
Virtual Clinical Trials Market - The global virtual clinical trials market size was valued at USD 8.3 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.7% from 2023 to 2030.
Mental Health Clinical Trials Market - The global mental health clinical trials market size was estimated at USD 2.73 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 8.3% from 2023 to 2030.
HIV Clinical Trials Industry Segmentation
Grand View Research has segmented the global HIV clinical trials market based on phase, study design, sponsor, and region:
HIV Clinical Trials Phase Outlook (Revenue, USD Million, 2018 - 2030)
- Phase I
- Phase II
- Phase III
- Phase IV
HIV Clinical Trials Study Design Outlook (Revenue, USD Million, 2018 - 2030)
- Interventional Studies
- Observational Studies
- Expanded Access Studies
HIV Clinical Trials Sponsor Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical & Biopharmaceutical Companies
- Non Profit Organizations
- Others
HIV Clinical Trials Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- Europe
- Asia Pacific
- Latin America
- MEA (Middle East & Africa)
Market Share Insights:
October 2021: Samsung BioLogics collaborated with Enzolytics Inc. This partnership aims to manufacture Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibody Therapies.
June 2021: Gilead Sciences, Inc. submitted a new drug application to the Food and Drug Administration (FDA). It is a long-acting HIV-1 capsid inhibitor that is used for the treatment of HIV-1 infection.
Key Companies profiled:
Some prominent players in the global HIV Clinical Trials Industry include
- PPD Inc.
- IQVIA Inc.
- Parexel International Corporation
- ICON plc
- Syneos Health
- WuXi AppTec
- Janssen Global Services, LLC
- Gilead Sciences, Inc.
- Bionor Holding AS
- Charles River Laboratories
- GSK plc.
- SGS SA
Order a free sample PDF of the HIV Clinical Trials Market Intelligence Study, published by Grand View Research.
No comments:
Post a Comment